Switch theme
Sign up to access all valuation multiples
Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which primarily sells its products through veterinarians and specialty pet retailers.
1923
34K+
LTM Revenue $20.1B
LTM EBITDA $5.0B
$80.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Colgate-Palmolive has a last 12-month revenue of $20.1B and a last 12-month EBITDA of $5.0B.
In the most recent fiscal year, Colgate-Palmolive achieved revenue of $20.1B and an EBITDA of $4.9B.
Colgate-Palmolive expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Colgate-Palmolive valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $19.5B | $20.1B | XXX | XXX | XXX |
| Gross Profit | $10.2B | $11.3B | XXX | XXX | XXX |
| Gross Margin | 53% | 56% | XXX | XXX | XXX |
| EBITDA | $4.2B | $4.9B | XXX | XXX | XXX |
| EBITDA Margin | 22% | 24% | XXX | XXX | XXX |
| Net Profit | $1.8B | $2.3B | XXX | XXX | XXX |
| Net Margin | 9% | 11% | XXX | XXX | XXX |
| Net Debt | $8.0B | $7.6B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of March 17, 2025, Colgate-Palmolive's stock price is $90.
Colgate-Palmolive has current market cap of $72.9B, and EV of $80.3B.
See Colgate-Palmolive trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $80.3B | $72.9B | XXX | XXX | XXX | XXX | $3.62 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of March 17, 2025, Colgate-Palmolive has market cap of $72.9B and EV of $80.3B.
Colgate-Palmolive's trades at 4.0x LTM EV/Revenue multiple, and 16.2x LTM EBITDA.
Analysts estimate Colgate-Palmolive's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Colgate-Palmolive and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $80.3B | XXX | XXX | XXX |
| EV/Revenue | 4.0x | XXX | XXX | XXX |
| EV/EBITDA | 16.5x | XXX | XXX | XXX |
| P/E | 25.2x | XXX | XXX | XXX |
| P/E/Growth | 4.4x | XXX | XXX | XXX |
| EV/FCF | 22.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpColgate-Palmolive's NTM/LTM revenue growth is 1%
Colgate-Palmolive's revenue per employee for the last fiscal year averaged $0.6M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Colgate-Palmolive's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Colgate-Palmolive's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Colgate-Palmolive and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 24% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 14% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 25% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.6M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 39% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Colgate-Palmolive acquired XXX companies to date.
Last acquisition by Colgate-Palmolive was XXXXXXXX, XXXXX XXXXX XXXXXX . Colgate-Palmolive acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Colgate-Palmolive founded? | Colgate-Palmolive was founded in 1923. |
| Where is Colgate-Palmolive headquartered? | Colgate-Palmolive is headquartered in United States of America. |
| How many employees does Colgate-Palmolive have? | As of today, Colgate-Palmolive has 34K+ employees. |
| Who is the CEO of Colgate-Palmolive? | Colgate-Palmolive's CEO is Mr. Noel R. Wallace. |
| Is Colgate-Palmolive publicy listed? | Yes, Colgate-Palmolive is a public company listed on NYS. |
| What is the stock symbol of Colgate-Palmolive? | Colgate-Palmolive trades under CL ticker. |
| When did Colgate-Palmolive go public? | Colgate-Palmolive went public in 1951. |
| Who are competitors of Colgate-Palmolive? | Similar companies to Colgate-Palmolive include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of Colgate-Palmolive? | Colgate-Palmolive's current market cap is $72.9B |
| What is the current revenue of Colgate-Palmolive? | Colgate-Palmolive's last 12-month revenue is $20.1B. |
| What is the current EBITDA of Colgate-Palmolive? | Colgate-Palmolive's last 12-month EBITDA is $5.0B. |
| What is the current EV/Revenue multiple of Colgate-Palmolive? | Current revenue multiple of Colgate-Palmolive is 4.0x. |
| What is the current EV/EBITDA multiple of Colgate-Palmolive? | Current EBITDA multiple of Colgate-Palmolive is 16.2x. |
| What is the current revenue growth of Colgate-Palmolive? | Colgate-Palmolive revenue growth between 2023 and 2024 was 3%. |
| Is Colgate-Palmolive profitable? | Yes, Colgate-Palmolive is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
